Etid klinik pou Obèsite nan Minnesota
29 etid pou Obèsite ap chèche patisipan nan sit nan Minnesota.
Vil nan Minnesota
Tèks ofisyèl etid la (Anglè)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
Ap rekriteFaz 3
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07564414A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07823608A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Mankato Clinic, Mankato
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- University of Minnesota, Minneapolis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Dilworth
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07815678A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374Exercise Response in Humans With Obesity
- Mayo Clinic in Rochester, Rochester
Ap rekriteEtid obsèvasyon
Laj 20 a 45 · Tout sèks · Mizajou Sep 11, 2026 · NCT05857150tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT05225233Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Ap rekriteFaz 2
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
Ap rekriteFaz 3
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
- Mayo Clinic in Rochester, Rochester
Ap rekriteVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 5, 2026 · NCT07031297Fibrosis Lessens After Metabolic Surgery
- Mayo Clinic, Rochester
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Jul 31, 2026 · NCT06374875A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06390345Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
- Mayo Clinic, Rochester
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Jun 11, 2026 · NCT06770049Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou May 22, 2026 · NCT06416969Circadian Rhythms in Human Adipose
- Mayo Clinic, Rochester
Ap rekriteVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Apr 14, 2026 · NCT06891534Regional Lipolysis Insulin Regulation
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Apr 13, 2026 · NCT06392854Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Mayo Clinic, Rochester
Ap rekriteFaz 4Mande peman pou patisipan yo
Laj 18 a 65 · Tout sèks · Mizajou Mar 11, 2026 · NCT07213466Insulin Regulation of Lipolysis and Lipolysis Proteins
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jan 28, 2026 · NCT03866408Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults
- University of Minnesota, Minneapolis
Ap rekriteFaz 1/2
Laj 21 a 75 · Tout sèks · Mizajou Dec 17, 2025 · NCT06226077Weight Loss Through Mayo Clinic Diet
- Mayo Clinic in Rochester, Rochester
Ap rekriteVolontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Oct 7, 2025 · NCT06862375Tirzepatide in PWS, HO and GNSO
- Children's Minnesota, Saint Paul
Ap rekriteFaz 4
Laj 18 a 26 · Tout sèks · Mizajou Sep 16, 2025 · NCT06901245Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.